Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Viable and Heat-Inactivated <i>Bifidobacterium bifidum</i> MIMBb75 Protect the Intestinal Barrier.

Microorganisms·2026
Same author

[Overview of the relevance of the intestinal mucus layer of the intestinal barrier - current state of knowledge and clinical perspective].

MMW Fortschritte der Medizin·2026
Same author

German Expert Consensus on Opioid-Induced Constipation (OIC): Recommendations and a Treatment Algorithm for Clinical Practice.

Journal of clinical medicine·2026
Same author

[Reason for consultation: bad breath].

MMW Fortschritte der Medizin·2026
Same author

[Detection and therapy of small intestinal bacterial overgrowth (SIBO)].

MMW Fortschritte der Medizin·2026
Same author

[Leaky Gut: What to do when patients show up with this diagnosis in primary care?]

MMW Fortschritte der Medizin·2025
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
See all related articles

Related Experiment Video

Updated: May 10, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

[Helicobacter pylori - Update 2013].

Martin Storr1

  • 1Medizinische Klinik II der Ludwig-Maximilians-Universität, München. gidoc@gmx.com

Medizinische Monatsschrift Fur Pharmazeuten
|June 14, 2013
PubMed
Summary
This summary is machine-generated.

Helicobacter pylori significantly contributes to stomach diseases like ulcers and cancer. Updated German guidelines and a new quadruple therapy offer improved diagnosis and treatment strategies for H. pylori infections.

More Related Videos

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

Related Experiment Videos

Last Updated: May 10, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

Area of Science:

  • Gastroenterology
  • Microbiology
  • Oncology

Background:

  • Helicobacter pylori is a key factor in peptic ulcers, gastric adenocarcinoma, gastric lymphoma, and autoimmune gastritis.
  • H. pylori also plays a role in dyspepsia symptom development.
  • Established diagnostic and treatment guidelines exist from the German Society of Digestive Diseases (DGVS) and the European Helicobacter Study Group (Maastricht-Consensus).

Purpose of the Study:

  • To outline and discuss the current state of the art in diagnosing and treating Helicobacter pylori infections in Germany.
  • To highlight the significance of updated guidelines and new quadruple eradication therapy.

Main Methods:

  • Review of current diagnostic and treatment guidelines for H. pylori.
  • Discussion of the newly approved quadruple eradication therapy in Germany.

Main Results:

  • H. pylori is implicated in several major gastrointestinal pathologies.
  • Updated guidelines and novel therapies are available for H. pylori management.
  • The introduction of quadruple therapy represents an advancement in H. pylori eradication.

Conclusions:

  • Effective diagnosis and treatment of H. pylori are crucial for managing associated gastrointestinal diseases.
  • The current landscape in Germany offers advanced therapeutic options for H. pylori infections.
  • Adherence to updated guidelines is recommended for optimal patient outcomes.